Alnylam Pharmaceuticals (ALNY) PT Lowered to $211 at BofA Securities
Tweet
Share
E-mail
Get Alerts ALNY Hot Sheet
Price: $228.65 +0.67%
Rating Summary:
29 Buy, 12 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
29 Buy, 12 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
BofA Securities analyst Tazeen Ahmad lowered the price target on Alnylam Pharmaceuticals (NASDAQ: ALNY) to $211.00 (from $227.00) while maintaining a Buy rating.
- 'CEO exit a surprise but fundamentals seem intact'
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Fiserv (FISV) PT Lowered to $60 at Freedom Broker
- Solar Industries (SOIL:IN) PT Raised to INR23,500 at ICICI Securities
- Tata Motors Passenger Vehicles (TMPV:IN) PT Raised to INR375 at ICICI Securities
Create E-mail Alert Related Categories
Analyst Comments, Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
